Fay reposted this
As more drugmakers aim for the lucrative weight loss market, patient challenges such as discontinuation and insurance complications linger. “Science is progressing, but what we’re seeing is employers and payers are much quicker to want to see lifestyle change first before a lot of these tools are deployed,” says Sam Faycurry, CEO of Fay. https://lnkd.in/eh-__w89